Skip to content

Pain Management After Elective Shoulder Surgery

Pain Management After Elective Shoulder Surgery: A Randomized Quantitative Study Comparing Hydromorphone With Piritramide

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03541759
Enrollment
48
Registered
2018-05-31
Start date
2018-01-02
Completion date
2018-05-17
Last updated
2018-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Pain

Keywords

Elective shoulder surgery, hydromorphone, piritramide

Brief summary

Postoperative pain management plays an important role in elective shoulder surgery. The aim of this randomized quantitative study is to compare two frequently used postoperative pain regimes (hydromorphone versus piritramide) regarding onset and duration after the effectiveness of the single-shot interscalene block has diminished.

Interventions

DRUGHydromorphone Hcl 4Mg Tab

Hydal retard 4Mg Tab 2 times after surgery as basic medication. Hydal retard 2.6Mg maximum 2 per 24h when NRS \> 5.

DRUGPiritramide 15mg s.c.

Dipidolor 15mg s.c. 2 times after surgery as basic medication. Dipidolor 7.5mg s.c. maximum 2 per 24h when NRS \> 5.

Sponsors

AUVA Traumazentrum Vienna Site UKH Meidling
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 99 Years
Healthy volunteers
No

Inclusion criteria

* all patients undergoing elective shoulder surgery with a single-shot interscalene plexus brachialis block in addition to general anesthesia * patients aged 18-99 years * patients being capable of giving an informed consent to participation in this study

Exclusion criteria

* patients aged below 18 years * patients with decompensated liver, heart or renal insufficiency * patients with any kind of lung disease * patients with a chronic pain syndrome * patients with a previous pain medication with more than 3 drugs over more than 3 months

Design outcomes

Primary

MeasureTime frameDescription
Pain management after elective shoulder surgery6 monthsComparison of hydromorphone versus piritramide using the numeric rating scale (NRS; range 0 - 10 points; level 0 representing no pain; level 10 representing the highest pain level)

Countries

Austria

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026